Jefferies Financial Group Inc.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 96223
NEW YORK, NY
Position in TEVA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,534,899
+$584,192 QoQ
Shares Held
45,304
+43.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#290
of 671 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Mar 31, 2024CallValue
$1,183,829
CallShares
83,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $24,089,483 across 13 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
370,092 | $9,389,234 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,697 | $3,628,635 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
293,670 | $2,325,866 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
10,630 | $1,791,580 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
45,304 | $1,534,899 | |
| 6 | ZTS |
Zoetis Inc.
|
18,525 | $1,331,206 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
34,027 | $1,231,777 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
27,400 | $991,880 |
All Filings in TEVA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,534,899 | 45,304 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $950,707 | 31,564 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $461,346 | 14,782 | Shares | Defined | 2026-02-09 | |
| 2024-12-31 | $331,657 | 15,048 | Shares | Defined | 2025-02-27 | |
| 2024-06-30 | $345,312 | 21,250 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,183,829 | 83,900 | Call | Defined | 2024-05-13 | |
| 2023-06-30 | $380,265 | 50,500 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $124,448 | 16,527 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $376,500 | 50,000 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $885,000 | 100,000 | Put | Defined | 2023-05-15 | |
| 2023-03-31 | $8,885 | 1,004 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,285,024 | 360,200 | Put | Defined | 2023-09-21 | |
| 2022-12-31 | $1,910,402 | 209,474 | Shares | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||